PTC THERAPEUTICS, INC. — Director's Dealing 2020

Dec 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2020-12-14

Reporting Person: Reeve Emma (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-14	Common Stock	M	1000	$33.02	Acquired	2650	Direct
2020-12-14	Common Stock	S	1000	$68.00	Disposed	1650	Direct
2020-12-14	Common Stock	M	972	$33.02	Acquired	2622	Direct
2020-12-14	Common Stock	S	972	$68.00	Disposed	1650	Direct
2020-12-15	Common Stock	M	1028	$33.02	Acquired	2678	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-14	Stock Option (Right to Buy)	$33.02	M	1000	Disposed	2029-01-21	Common Stock (1000)	Direct
2020-12-14	Stock Option (Right to Buy)	$33.02	M	972	Disposed	2029-01-21	Common Stock (972)	Direct
2020-12-15	Stock Option (Right to Buy)	$33.02	M	1028	Disposed	2029-01-21	Common Stock (1028)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$33.63	2028-12-13	Common Stock (14000)	14000	Direct
Stock Option (Right to Buy)	$33.63	2028-12-13	Common Stock (1167)	1167	Direct
Stock Option (Right to Buy)	$51.16	2030-01-28	Common Stock (10000)	10000	Direct

Footnotes

F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on August 29, 2020.

F2: Currently exercisable.

F3: This option award vests in thirty-six approximately equal monthly installments, commencing on January 14, 2019 and continuing on each successive monthly anniversary of thereafter, ending on the third year anniversary of the grant date.

F4: This option was granted on January 29, 2020 and vests over one year in twelve equal monthly installments, commencing on February 29, 2020.